MIF invests in KAHR to explore lead immunotherapy drug for multiple myeloma
KAHR Medical, a clinical stage biotech company that is developing a treatment for solid tumors…
November 18, 2022 - 3 minutes
KAHR Medical, a clinical stage biotech company that is developing a treatment for solid tumors…